text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 321-64-2 | Product Number: T3994

Tacrine


Purity: >98.0%(T)(HPLC)
Synonyms:
  • 1,2,3,4-Tetrahydroacridin-9-amine
  • 1,2,3,4-Tetrahydro-9-acridinamine
  • 9-Amino-1,2,3,4-tetrahydroacridine
  • THA
Product Documents:
250MG
€43.00
1   3  
1G
€151.00
1   5  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number T3994
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__3H__1__4N__2 = 198.27 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive
Packaging and Container 1G-Glass Bottle with Plastic Insert (View image),  250MG-Glass Bottle with Plastic Insert (View image)
CAS RN 321-64-2
Reaxys Registry Number 147610
PubChem Substance ID 468593059
MDL Number

MFCD00046923

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 181.0 to 185.0 °C
NMR confirm to structure
Properties (reference)
Melting Point 183 °C
Maximum Absorption Wavelength 325(EtOH) nm
GHS
Pictogram Pictogram
Signal Word Danger
Hazard Statements H301 : Toxic if swallowed.
H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
Related Laws:
EC Number 206-291-2
RTECS# AR9532100
Transport Information:
UN Number UN2811
Class 6.1
Packing Group III
HS Number 2933998090
Application
Mitochondria research

References


Application
Tacrine: A Reversible Cholinesterase Inhibitor

Tacrine is a reversible cholinesterase inhibitor, and the first approved agent for the treatment of Alzheimer's disease.1) The mechanism of action of tacrine is thought to inhibit the metabolism of acetylcholine and therefore extending its activity and raising levels in the cerebral cortex.2,3) However, since tacrine shows various side effects and toxicity, the development of the next generation inhibitors such as donepezil [D4099 (HCl salt)] is underway.3,4) (The product is for research purpose only.)

References

Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.